Non-Standardized Fungal Allergenic Extract [EPC]

Non-Standardized Fungal Allergenic Extract [EPC] was reported 2151 times

Drugs of the Non-Standardized Fungal Allergenic Extract [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DIFFUSE AXONAL INJURY 9 0.1084
1 SEPTIC NECROSIS 3 0.0833
2 TUMOUR INFLAMMATION 6 0.0536
3 EPILEPTIC ENCEPHALOPATHY 10 0.0448
4 APPLICATION SITE INJURY 6 0.0316
5 MITRAL VALVE SCLEROSIS 5 0.0289
6 HYDROCHOLECYSTIS 5 0.0270
7 EYELID EROSION 2 0.0230
8 GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY 5 0.0226
9 APPLICATION SITE OEDEMA 6 0.0185
10 POLYMERASE CHAIN REACTION POSITIVE 6 0.0172
11 AMYOTROPHY 6 0.0155
12 INFUSION SITE INJURY 2 0.0114
13 LIP INFECTION 2 0.0094
14 WHITE MATTER LESION 11 0.0087
15 NECROSIS ISCHAEMIC 4 0.0087
16 EJECTION FRACTION 5 0.0086
17 CHRONIC LEFT VENTRICULAR FAILURE 3 0.0083
18 ENTEROBACTER SEPSIS 3 0.0081
19 FACIAL WASTING 2 0.0074
20 CARDIOVASCULAR INSUFFICIENCY 12 0.0074
21 BACTERIAL VULVOVAGINITIS 2 0.0069
22 BONE NEOPLASM 7 0.0065
23 DEFAECATION DISORDER 4 0.0060
24 INFLAMMATION OF WOUND 2 0.0060
25 GAIT SPASTIC 2 0.0058
26 PNEUMONIA STREPTOCOCCAL 5 0.0046
27 PSEUDOMEMBRANOUS COLITIS 10 0.0045
28 CORONARY ANGIOPLASTY 2 0.0044
29 BLADDER MASS 2 0.0040
30 CARBOHYDRATE ANTIGEN 19-9 INCREASED 2 0.0038
31 HYPERMETABOLISM 2 0.0038
32 PERIORBITAL PAIN 3 0.0035
33 MUCOSAL DRYNESS 7 0.0035
34 LACRIMAL DISORDER 2 0.0034
35 GASTROINTESTINAL WALL THICKENING 5 0.0033
36 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
37 CLOSTRIDIUM TEST POSITIVE 7 0.0032
38 GENE MUTATION 6 0.0030
39 LICHEN SCLEROSUS 2 0.0029
40 INFUSION SITE DISCHARGE 5 0.0028
41 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
42 ESCHAR 2 0.0027
43 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 2 0.0026
44 BREAST SWELLING 7 0.0026
45 URINARY TRACT OBSTRUCTION 6 0.0025
46 FACET JOINT SYNDROME 8 0.0025
47 HYPERTONIC BLADDER 7 0.0024
48 COVID-19 IMMUNISATION 2 0.0024
49 SEROMA 3 0.0024
50 INFECTED BITE 2 0.0024
51 APTYALISM 2 0.0023
52 AORTIC ARTERIOSCLEROSIS 6 0.0023
53 INFUSION SITE RASH 3 0.0022
54 NEOPLASM RECURRENCE 7 0.0021
55 HEPATIC CYST 7 0.0021
56 BLOOD IRON ABNORMAL 2 0.0020
57 INFUSION SITE INDURATION 3 0.0020
58 GASTROINTESTINAL SOUNDS ABNORMAL 10 0.0020
59 MIXED LIVER INJURY 6 0.0020
60 BONE EROSION 7 0.0020
61 BUTTERFLY RASH 2 0.0020
62 INFUSION SITE DISCOMFORT 2 0.0019
63 MEGACOLON 3 0.0019
64 GASTROINTESTINAL STOMA COMPLICATION 3 0.0019
65 SKIN ABRASION 9 0.0019
66 SLEEP DEFICIT 4 0.0019
67 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
68 INNER EAR DISORDER 2 0.0019
69 OCULOGYRIC CRISIS 4 0.0019
70 INFUSION SITE BRUISING 4 0.0019
71 INFUSION SITE MASS 2 0.0018
72 IRON DEFICIENCY 8 0.0018
73 APPLICATION SITE DISCOLOURATION 7 0.0017
74 ANAL INCONTINENCE 15 0.0017
75 EMERGENCY CARE 5 0.0016
76 HORMONE LEVEL ABNORMAL 8 0.0016
77 ESSENTIAL HYPERTENSION 3 0.0016
78 METAMORPHOPSIA 3 0.0016
79 INJECTION SITE CELLULITIS 3 0.0016
80 BLADDER DISCOMFORT 2 0.0016
81 INFUSION SITE PRURITUS 5 0.0016
82 LARGE INTESTINE PERFORATION 11 0.0016
83 NOCARDIOSIS 4 0.0016
84 INFUSION SITE IRRITATION 2 0.0016
85 RHINOVIRUS INFECTION 6 0.0015
86 INFUSION SITE HAEMORRHAGE 5 0.0015
87 CELL DEATH 3 0.0015
88 JOINT CREPITATION 3 0.0015
89 HUMERUS FRACTURE 7 0.0015
90 EMBOLISM 12 0.0014
91 HAIR GROWTH ABNORMAL 10 0.0014
92 COVID-19 PNEUMONIA 17 0.0014
93 INFUSION SITE SWELLING 9 0.0014
94 JOINT INSTABILITY 2 0.0014
95 BUNDLE BRANCH BLOCK LEFT 6 0.0014
96 DRUG TOLERANCE 7 0.0014
97 CLOSTRIDIUM DIFFICILE INFECTION 30 0.0014
98 TOOTH DISCOLOURATION 4 0.0014
99 CHOLESTATIC LIVER INJURY 3 0.0013
100 INFUSION SITE PAIN 17 0.0013
101 PROSTATITIS 4 0.0013
102 NEPHROGENIC ANAEMIA 6 0.0013
103 GASTROINTESTINAL OBSTRUCTION 3 0.0012
104 ARTHRITIS BACTERIAL 5 0.0012
105 HYPERVOLAEMIA 6 0.0012
106 BILIARY DYSKINESIA 2 0.0012
107 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
108 AORTIC VALVE INCOMPETENCE 5 0.0012
109 FEMORAL NECK FRACTURE 6 0.0012
110 EMOTIONAL POVERTY 2 0.0011
111 RENAL CYST 9 0.0011
112 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
113 AORTIC VALVE STENOSIS 2 0.0011
114 SHOULDER ARTHROPLASTY 3 0.0011
115 MENINGITIS ASEPTIC 5 0.0011
116 BRAIN OEDEMA 14 0.0011
117 CHONDROPATHY 3 0.0011
118 TACHYPNOEA 15 0.0011
119 VASCULAR DEVICE INFECTION 5 0.0011
120 FAECES SOFT 8 0.0011
121 CLUMSINESS 3 0.0011
122 POLYURIA 9 0.0011
123 HAEMOGLOBIN INCREASED 5 0.0011
124 THROMBOCYTOSIS 4 0.0011
125 HYPOMANIA 4 0.0011
126 BLOOD CHOLESTEROL DECREASED 2 0.0011
127 IMPATIENCE 2 0.0011
128 MICTURITION URGENCY 12 0.0010
129 WRONG PRODUCT ADMINISTERED 7 0.0010
130 SPINAL CORD COMPRESSION 4 0.0010
131 URINE ODOUR ABNORMAL 6 0.0010
132 FOAMING AT MOUTH 2 0.0010
133 VULVOVAGINAL PRURITUS 5 0.0010
134 DEVICE CONNECTION ISSUE 2 0.0009
135 LIP OEDEMA 4 0.0009
136 DUODENAL ULCER PERFORATION 7 0.0009
137 FOREIGN BODY SENSATION IN EYES 6 0.0009
138 HEPATIC PAIN 4 0.0009
139 ACUTE RESPIRATORY FAILURE 18 0.0009
140 EAR PAIN 18 0.0009
141 OCULAR ICTERUS 4 0.0009
142 TONGUE DISCOLOURATION 4 0.0009
143 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
144 HEART RATE ABNORMAL 5 0.0009
145 DYSURIA 33 0.0009
146 MULTIPLE ALLERGIES 7 0.0009
147 LARGE INTESTINAL HAEMORRHAGE 2 0.0009
148 WOUND DEHISCENCE 3 0.0009
149 BLOOD LOSS ANAEMIA 2 0.0009
150 PERONEAL NERVE PALSY 5 0.0009
151 DERMATITIS CONTACT 10 0.0009
152 REGURGITATION 3 0.0009
153 DENGUE FEVER 2 0.0009
154 SENSORY LOSS 7 0.0009
155 MICTURITION DISORDER 3 0.0009
156 ABNORMAL FAECES 7 0.0009
157 TYPE I HYPERSENSITIVITY 3 0.0009
158 NECROTISING FASCIITIS 3 0.0009
159 MENSTRUAL DISORDER 7 0.0008
160 EOSINOPHIL COUNT DECREASED 2 0.0008
161 BREAST CANCER METASTATIC 9 0.0008
162 ODYNOPHAGIA 5 0.0008
163 GANGRENE 5 0.0008
164 NOCTURIA 10 0.0008
165 CUTANEOUS VASCULITIS 3 0.0008
166 HAEMATOLOGICAL INFECTION 2 0.0008
167 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
168 CARTILAGE INJURY 2 0.0008
169 MUCOUS STOOLS 4 0.0008
170 FLUID INTAKE REDUCED 4 0.0008
171 HYPERPARATHYROIDISM SECONDARY 2 0.0008
172 LABYRINTHITIS 2 0.0008
173 FACE INJURY 3 0.0008
174 TONGUE OEDEMA 3 0.0008
175 INSURANCE ISSUE 12 0.0008
176 ENDOCARDITIS 4 0.0008
177 OESOPHAGEAL DISORDER 3 0.0008
178 BLOOD CHLORIDE DECREASED 2 0.0008
179 WOUND SECRETION 3 0.0008
180 BRAIN FOG 12 0.0008
181 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
182 FOOD CRAVING 4 0.0008
183 TRICUSPID VALVE INCOMPETENCE 6 0.0008
184 OBSTRUCTION 3 0.0008
185 FUNGAL SKIN INFECTION 3 0.0007
186 URINARY INCONTINENCE 22 0.0007
187 BLOOD SODIUM INCREASED 2 0.0007
188 ULCER HAEMORRHAGE 5 0.0007
189 ABDOMINAL RIGIDITY 2 0.0007
190 DECUBITUS ULCER 6 0.0007
191 PERIPHERAL ISCHAEMIA 3 0.0007
192 LIP BLISTER 2 0.0007
193 HYPERKERATOSIS 4 0.0007
194 LARGE INTESTINE POLYP 5 0.0007
195 NECROSIS 4 0.0007
196 INFUSION SITE ERYTHEMA 6 0.0007
197 CEREBRAL THROMBOSIS 2 0.0007
198 BLADDER DISORDER 7 0.0007
199 JOINT LOCK 2 0.0007
200 ABSCESS LIMB 3 0.0007
201 HORDEOLUM 3 0.0007
202 CYSTITIS 22 0.0007
203 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
204 URINARY RETENTION 23 0.0007
205 DIVERTICULUM INTESTINAL 3 0.0007
206 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
207 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
208 HYDRONEPHROSIS 5 0.0007
209 EYE INJURY 2 0.0007
210 BREAST PAIN 7 0.0007
211 ATRIOVENTRICULAR BLOCK 5 0.0006
212 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
213 YELLOW SKIN 3 0.0006
214 BLOOD BLISTER 2 0.0006
215 BLOOD CREATININE DECREASED 2 0.0006
216 VAGINAL INFECTION 3 0.0006
217 SEASONAL ALLERGY 9 0.0006
218 FOREIGN BODY IN THROAT 2 0.0006
219 FAECAL CALPROTECTIN INCREASED 2 0.0006
220 SARCOIDOSIS 3 0.0006
221 FUNGAL INFECTION 21 0.0006
222 BLADDER PAIN 2 0.0006
223 OCULAR DISCOMFORT 7 0.0006
224 POLLAKIURIA 26 0.0006
225 VULVOVAGINAL PAIN 3 0.0006
226 EYE PAIN 35 0.0006
227 MITRAL VALVE INCOMPETENCE 7 0.0006
228 HEPATOMEGALY 6 0.0006
229 VITREOUS FLOATERS 6 0.0006
230 HOSPICE CARE 6 0.0006
231 VEIN DISORDER 3 0.0006
232 VAGINAL DISCHARGE 6 0.0006
233 CANDIDA INFECTION 10 0.0006
234 URINARY TRACT INFECTION 101 0.0006
235 DRY THROAT 6 0.0006
236 BLOOD IRON DECREASED 7 0.0006
237 MACULAR DEGENERATION 7 0.0006
238 VITAMIN D DECREASED 5 0.0006
239 PHOTOPHOBIA 11 0.0006
240 PRODUCT COLOUR ISSUE 3 0.0006
241 CACHEXIA 3 0.0006
242 TEMPERATURE INTOLERANCE 6 0.0006
243 LYMPHOEDEMA 4 0.0006
244 CHROMATURIA 13 0.0006
245 FEELING COLD 16 0.0006
246 EAR PRURITUS 2 0.0006
247 BLOOD LACTIC ACID INCREASED 3 0.0006
248 EMBOLIC STROKE 2 0.0006
249 HAEMORRHOIDS 11 0.0006
250 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
251 COMPRESSION FRACTURE 3 0.0006
252 ANAL ABSCESS 3 0.0006
253 MUSCLE ATROPHY 7 0.0006
254 PRESCRIBED UNDERDOSE 11 0.0006
255 OESOPHAGITIS 6 0.0005
256 BLOOD PHOSPHORUS DECREASED 2 0.0005
257 FEELING DRUNK 4 0.0005
258 LOCALISED INFECTION 13 0.0005
259 HEAD INJURY 17 0.0005
260 HEPATIC STEATOSIS 10 0.0005
261 NODULE 7 0.0005
262 IMPULSIVE BEHAVIOUR 2 0.0005
263 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
264 EYE INFECTION 6 0.0005
265 PERIORBITAL SWELLING 3 0.0005
266 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
267 ENCEPHALOPATHY 13 0.0005
268 CATHETER SITE INFECTION 2 0.0005
269 AORTIC ANEURYSM 4 0.0005
270 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
271 GASTRIC INFECTION 2 0.0005
272 BOWEL MOVEMENT IRREGULARITY 4 0.0005
273 GINGIVAL DISORDER 2 0.0005
274 MOUTH SWELLING 3 0.0005
275 MADAROSIS 6 0.0005
276 PRESCRIBED OVERDOSE 10 0.0005
277 APHTHOUS ULCER 4 0.0005
278 BASAL CELL CARCINOMA 8 0.0005
279 HYPOVOLAEMIA 3 0.0005
280 EPIGASTRIC DISCOMFORT 2 0.0005
281 VIRAL INFECTION 17 0.0005
282 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
283 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
284 LIGAMENT SPRAIN 5 0.0005
285 RESPIRATORY TRACT INFECTION 13 0.0005
286 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
287 INTRACRANIAL ANEURYSM 2 0.0005
288 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
289 ENURESIS 2 0.0005
290 TASTE DISORDER 10 0.0005
291 TENSION 3 0.0005
292 VULVOVAGINAL BURNING SENSATION 3 0.0005
293 GOITRE 2 0.0005
294 SMALL INTESTINAL OBSTRUCTION 6 0.0005
295 DRUG LEVEL INCREASED 8 0.0005
296 HYPOXIA 17 0.0005
297 PRE-EXISTING CONDITION IMPROVED 3 0.0005
298 LYMPHADENOPATHY 17 0.0005
299 DYSSTASIA 14 0.0005
300 GAIT INABILITY 16 0.0005
301 WEIGHT FLUCTUATION 5 0.0005
302 BLOOD URINE PRESENT 9 0.0005
303 INCONTINENCE 5 0.0005
304 HEPATIC CYTOLYSIS 6 0.0005
305 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
306 HYPOAESTHESIA ORAL 7 0.0005
307 HEPATIC LESION 2 0.0005
308 OSTEOPENIA 7 0.0005
309 CHAPPED LIPS 2 0.0005
310 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
311 PRODUCT PREPARATION ISSUE 3 0.0005
312 SOMNAMBULISM 3 0.0005
313 HYPOGAMMAGLOBULINAEMIA 3 0.0005
314 DYSPHEMIA 2 0.0005
315 SPINAL OSTEOARTHRITIS 4 0.0005
316 TOOTH INFECTION 6 0.0005
317 HAEMORRHAGIC ANAEMIA 2 0.0005
318 WALKING AID USER 3 0.0005
319 GASTROINTESTINAL INFECTION 4 0.0004
320 THERAPY NON-RESPONDER 20 0.0004
321 BLOOD PRESSURE INCREASED 68 0.0004
322 PRODUCT USE COMPLAINT 7 0.0004
323 STATUS EPILEPTICUS 5 0.0004
324 BALANCE DISORDER 38 0.0004
325 END STAGE RENAL DISEASE 8 0.0004
326 INTERNAL HAEMORRHAGE 5 0.0004
327 ONYCHOCLASIS 3 0.0004
328 NERVE COMPRESSION 4 0.0004
329 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
330 DIVERTICULITIS 12 0.0004
331 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
332 HYPERTRANSAMINASAEMIA 3 0.0004
333 PRODUCT DISTRIBUTION ISSUE 4 0.0004
334 HYPOPHAGIA 11 0.0004
335 GASTRITIS EROSIVE 2 0.0004
336 DEFAECATION URGENCY 3 0.0004
337 BLINDNESS UNILATERAL 6 0.0004
338 BLOOD SODIUM DECREASED 8 0.0004
339 GASTROINTESTINAL DISORDER 38 0.0004
340 FLATULENCE 24 0.0004
341 COLITIS MICROSCOPIC 2 0.0004
342 DYSPEPSIA 41 0.0004
343 GASTROINTESTINAL TOXICITY 2 0.0004
344 CRYING 15 0.0004
345 FIBROMYALGIA 10 0.0004
346 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
347 AUTOIMMUNE DISORDER 4 0.0004
348 ORAL DISORDER 3 0.0004
349 SCAR 7 0.0004
350 HAEMATURIA 14 0.0004
351 KIDNEY INFECTION 8 0.0004
352 THERAPY CHANGE 4 0.0004
353 TENDON RUPTURE 5 0.0004
354 ARTHROPOD BITE 3 0.0004
355 PHARYNGITIS 5 0.0004
356 BREAST TENDERNESS 3 0.0004
357 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
358 INTESTINAL OBSTRUCTION 15 0.0004
359 LYMPHOCYTE COUNT DECREASED 7 0.0004
360 FEELING HOT 24 0.0004
361 GOUT 7 0.0004
362 ROTATOR CUFF SYNDROME 5 0.0004
363 RIB FRACTURE 8 0.0004
364 CONCUSSION 3 0.0004
365 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
366 POOR VENOUS ACCESS 4 0.0004
367 TENDERNESS 4 0.0004
368 GASTROINTESTINAL INFLAMMATION 3 0.0004
369 RESTLESSNESS 14 0.0004
370 SINUSITIS 39 0.0004
371 DRUG SCREEN POSITIVE 3 0.0004
372 RENAL PAIN 4 0.0004
373 ULCER 6 0.0004
374 GINGIVAL PAIN 3 0.0004
375 ANORECTAL DISCOMFORT 2 0.0004
376 COVID-19 66 0.0004
377 ATRIAL FLUTTER 3 0.0004
378 RETCHING 8 0.0004
379 IMPAIRED WORK ABILITY 8 0.0004
380 CONTUSION 36 0.0004
381 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
382 TINNITUS 17 0.0004
383 BEHAVIOUR DISORDER 2 0.0004
384 PHARYNGITIS STREPTOCOCCAL 4 0.0004
385 FAECES DISCOLOURED 8 0.0004
386 POST PROCEDURAL INFECTION 3 0.0004
387 VAGINAL HAEMORRHAGE 16 0.0004
388 CHRONIC KIDNEY DISEASE 28 0.0004
389 SKIN LACERATION 4 0.0004
390 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
391 ASTHENOPIA 2 0.0004
392 CONSTIPATION 79 0.0004
393 ERUCTATION 7 0.0004
394 PLEURAL EFFUSION 22 0.0004
395 NERVE INJURY 4 0.0004
396 HOT FLUSH 27 0.0004
397 SKIN FISSURES 7 0.0004
398 BURNING SENSATION 25 0.0004
399 BLOOD CALCIUM DECREASED 4 0.0004
400 SINUS DISORDER 7 0.0004
401 CHOLECYSTITIS ACUTE 2 0.0004
402 IMPAIRED DRIVING ABILITY 4 0.0004
403 EXERCISE TOLERANCE DECREASED 2 0.0003
404 DELIRIUM 12 0.0003
405 HALLUCINATION 26 0.0003
406 ELECTROLYTE IMBALANCE 4 0.0003
407 URINE OUTPUT DECREASED 3 0.0003
408 DEVICE USE ISSUE 6 0.0003
409 COLITIS 13 0.0003
410 INTENTIONAL PRODUCT MISUSE 30 0.0003
411 GASTROENTERITIS 5 0.0003
412 FALL 114 0.0003
413 GROIN PAIN 3 0.0003
414 IMMUNOSUPPRESSION 3 0.0003
415 ILLNESS 35 0.0003
416 ENERGY INCREASED 2 0.0003
417 LABORATORY TEST ABNORMAL 10 0.0003
418 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
419 CELLULITIS 17 0.0003
420 THIRST 6 0.0003
421 PULMONARY MASS 5 0.0003
422 COLON CANCER 5 0.0003
423 GASTROOESOPHAGEAL REFLUX DISEASE 27 0.0003
424 HYPERLIPIDAEMIA 4 0.0003
425 PAIN OF SKIN 9 0.0003
426 CONFUSIONAL STATE 54 0.0003
427 LIMB INJURY 9 0.0003
428 SWELLING 31 0.0003
429 BURSITIS 4 0.0003
430 NEPHROLITHIASIS 15 0.0003
431 RETINAL DETACHMENT 3 0.0003
432 INCREASED TENDENCY TO BRUISE 3 0.0003
433 IRON DEFICIENCY ANAEMIA 3 0.0003
434 INFECTION 47 0.0003
435 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
436 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
437 GENERALISED OEDEMA 4 0.0003
438 MUSCULOSKELETAL CHEST PAIN 5 0.0003
439 ANKLE FRACTURE 5 0.0003
440 TENDONITIS 5 0.0003
441 CHOLANGITIS 2 0.0003
442 THINKING ABNORMAL 6 0.0003
443 ABDOMINAL DISCOMFORT 54 0.0003
444 SEPTIC SHOCK 14 0.0003
445 INFUSION SITE EXTRAVASATION 2 0.0003
446 ARTERIOSCLEROSIS 3 0.0003
447 ATRIAL FIBRILLATION 31 0.0003
448 DIARRHOEA 205 0.0003
449 PNEUMOTHORAX 5 0.0003
450 TOOTH DISORDER 7 0.0003
451 MIGRAINE 30 0.0003
452 GAIT DISTURBANCE 60 0.0003
453 PRODUCT SUBSTITUTION ISSUE 18 0.0003
454 PULMONARY OEDEMA 14 0.0003
455 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
456 HAEMOGLOBIN ABNORMAL 2 0.0003
457 SKIN ULCER 8 0.0003
458 DRY MOUTH 25 0.0003
459 BLOOD POTASSIUM INCREASED 5 0.0003
460 PHARYNGEAL SWELLING 3 0.0003
461 RENAL TUBULAR NECROSIS 3 0.0003
462 JOINT STIFFNESS 8 0.0003
463 ASPERGILLUS INFECTION 2 0.0003
464 BEDRIDDEN 4 0.0003
465 ORAL CANDIDIASIS 4 0.0003
466 DYSGRAPHIA 2 0.0003
467 STAPHYLOCOCCAL INFECTION 10 0.0003
468 BLOOD PRESSURE ABNORMAL 6 0.0003
469 DYSMENORRHOEA 4 0.0003
470 SKIN DISORDER 10 0.0003
471 EYE HAEMORRHAGE 4 0.0003
472 VISION BLURRED 41 0.0003
473 BLOOD UREA INCREASED 5 0.0003
474 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
475 QUALITY OF LIFE DECREASED 4 0.0003
476 BREAST MASS 2 0.0003
477 FEEDING DISORDER 6 0.0003
478 FLUSHING 30 0.0003
479 TOOTH ABSCESS 3 0.0003
480 GINGIVAL BLEEDING 4 0.0003
481 EAR DISCOMFORT 3 0.0003
482 THERAPY CESSATION 15 0.0003
483 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
484 PERIPHERAL SWELLING 45 0.0003
485 OSTEOPOROSIS 12 0.0003
486 MUSCULOSKELETAL DISCOMFORT 5 0.0003
487 NASAL CONGESTION 17 0.0003
488 PULMONARY HYPERTENSION 6 0.0003
489 ORAL DISCOMFORT 4 0.0003
490 ACUTE KIDNEY INJURY 44 0.0003
491 FORMICATION 2 0.0003
492 HYPOMAGNESAEMIA 4 0.0003
493 COORDINATION ABNORMAL 4 0.0003
494 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
495 CARPAL TUNNEL SYNDROME 4 0.0003
496 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
497 DEVICE OCCLUSION 4 0.0003
498 IRRITABILITY 17 0.0003
499 PRODUCT DOSE OMISSION ISSUE 83 0.0003
500 EATING DISORDER 6 0.0003
501 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
502 INTENTIONAL DOSE OMISSION 8 0.0003
503 BODY HEIGHT DECREASED 3 0.0003
504 HIP FRACTURE 9 0.0003
505 RED BLOOD CELL COUNT DECREASED 8 0.0003
506 BACK PAIN 65 0.0003
507 HEREDITARY ANGIOEDEMA 3 0.0003
508 NIGHT SWEATS 9 0.0003
509 POOR QUALITY SLEEP 6 0.0003
510 GASTROENTERITIS VIRAL 5 0.0003
511 RASH PRURITIC 15 0.0003
512 PULMONARY THROMBOSIS 3 0.0003
513 EYE DISORDER 9 0.0003
514 TOOTH FRACTURE 3 0.0003
515 MULTIPLE SCLEROSIS 13 0.0003
516 BLINDNESS TRANSIENT 2 0.0003
517 DENTAL CARIES 3 0.0003
518 BLOOD GLUCOSE ABNORMAL 5 0.0003
519 FOOT DEFORMITY 3 0.0003
520 INSOMNIA 72 0.0003
521 OROPHARYNGEAL PAIN 25 0.0003
522 SLEEP DISORDER 19 0.0003
523 SEPSIS 30 0.0003
524 PNEUMONIA 87 0.0003
525 ORAL PAIN 6 0.0003
526 MIDDLE INSOMNIA 5 0.0003
527 SKIN INFECTION 3 0.0003
528 EPISTAXIS 20 0.0003
529 SPEECH DISORDER 14 0.0003
530 GASTRITIS 7 0.0003
531 LACRIMATION INCREASED 8 0.0003
532 BLOOD COUNT ABNORMAL 4 0.0003
533 FOOT FRACTURE 5 0.0003
534 CARDIO-RESPIRATORY ARREST 11 0.0003
535 EAR INFECTION 7 0.0003
536 MUSCULOSKELETAL DISORDER 5 0.0003
537 MULTIPLE SCLEROSIS RELAPSE 18 0.0003
538 CHOLECYSTECTOMY 3 0.0003
539 DEHYDRATION 35 0.0003
540 DRUG DISPENSING ERROR 4 0.0003
541 HIP ARTHROPLASTY 4 0.0003
542 DISSOCIATION 2 0.0003
543 GASTRIC HAEMORRHAGE 3 0.0003
544 EYE IRRITATION 15 0.0003
545 FOOD ALLERGY 2 0.0003
546 FEELING ABNORMAL 62 0.0003
547 HERNIA 5 0.0003
548 OEDEMA 14 0.0003
549 HYPOALBUMINAEMIA 2 0.0003
550 BRONCHITIS 19 0.0003
551 MOOD ALTERED 7 0.0003
552 HYPERKALAEMIA 9 0.0003
553 MUSCLE SPASMS 47 0.0003
554 HYPOACUSIS 11 0.0003
555 SKIN LESION 7 0.0003
556 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
557 AFFECTIVE DISORDER 2 0.0003
558 WEIGHT DECREASED 71 0.0003
559 DECREASED APPETITE 59 0.0003
560 PLATELET COUNT DECREASED 27 0.0003
561 ASTHENIA 95 0.0003
562 BLOOD ALBUMIN DECREASED 2 0.0003
563 MEDICATION ERROR 14 0.0003
564 RESPIRATORY TRACT CONGESTION 4 0.0003
565 SCIATICA 4 0.0003
566 WRIST FRACTURE 3 0.0003
567 METABOLIC ACIDOSIS 8 0.0002
568 BLOOD DISORDER 2 0.0002
569 MOVEMENT DISORDER 8 0.0002
570 ABDOMINAL DISTENSION 26 0.0002
571 FULL BLOOD COUNT DECREASED 5 0.0002
572 ABDOMINAL PAIN UPPER 51 0.0002
573 PALPITATIONS 29 0.0002
574 FRUSTRATION TOLERANCE DECREASED 2 0.0002
575 HYPERGLYCAEMIA 9 0.0002
576 PANIC ATTACK 9 0.0002
577 VERTIGO 15 0.0002
578 COLITIS ULCERATIVE 11 0.0002
579 BACK DISORDER 4 0.0002
580 DISCOMFORT 15 0.0002
581 ASPHYXIA 2 0.0002
582 IMPAIRED HEALING 8 0.0002
583 HYPERAESTHESIA 2 0.0002
584 ESCHERICHIA INFECTION 2 0.0002
585 HYPOAESTHESIA 36 0.0002
586 EOSINOPHIL COUNT INCREASED 2 0.0002
587 DERMATITIS 5 0.0002
588 HAEMODIALYSIS 2 0.0002
589 DRUG INTOLERANCE 23 0.0002
590 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
591 PAIN IN EXTREMITY 70 0.0002
592 DEPRESSION 54 0.0002
593 FACE OEDEMA 4 0.0002
594 HYPERTENSION 50 0.0002
595 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
596 CARDIAC DISORDER 22 0.0002
597 CATARACT 14 0.0002
598 INTRAOCULAR PRESSURE INCREASED 3 0.0002
599 MEMORY IMPAIRMENT 32 0.0002
600 HEADACHE 146 0.0002
601 NECK PAIN 13 0.0002
602 ANURIA 2 0.0002
603 OCULAR HYPERAEMIA 11 0.0002
604 CORONARY ARTERY DISEASE 7 0.0002
605 INFLUENZA LIKE ILLNESS 19 0.0002
606 SWELLING FACE 15 0.0002
607 PRODUCT DOSE OMISSION 15 0.0002
608 PARAESTHESIA 36 0.0002
609 SYRINGE ISSUE 4 0.0002
610 EOSINOPHILIA 4 0.0002
611 IMMUNE SYSTEM DISORDER 3 0.0002
612 FATIGUE 177 0.0002
613 GRIP STRENGTH DECREASED 2 0.0002
614 MELAENA 5 0.0002
615 APPLICATION SITE PAIN 5 0.0002
616 LIMB DISCOMFORT 7 0.0002
617 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
618 ARTHRALGIA 94 0.0002
619 VISUAL IMPAIRMENT 28 0.0002
620 HEAD DISCOMFORT 4 0.0002
621 HAIR TEXTURE ABNORMAL 3 0.0002
622 GLOSSODYNIA 5 0.0002
623 HEAVY MENSTRUAL BLEEDING 2 0.0002
624 HEART RATE INCREASED 22 0.0002
625 HEART RATE IRREGULAR 5 0.0002
626 LEUKOCYTOSIS 4 0.0002
627 LIP DRY 2 0.0002
628 RESTLESS LEGS SYNDROME 4 0.0002
629 C-REACTIVE PROTEIN INCREASED 8 0.0002
630 HYPOTHYROIDISM 7 0.0002
631 MUSCLE TWITCHING 5 0.0002
632 HYPOKALAEMIA 10 0.0002
633 SEIZURE 25 0.0002
634 FLUID RETENTION 11 0.0002
635 LACTIC ACIDOSIS 7 0.0002
636 ARTHROPATHY 12 0.0002
637 HAEMOPTYSIS 6 0.0002
638 ABDOMINAL PAIN 50 0.0002
639 BLOOD CHOLESTEROL INCREASED 10 0.0002
640 ALOPECIA 42 0.0002
641 FLANK PAIN 2 0.0002
642 PAIN 131 0.0002
643 SKIN REACTION 3 0.0002
644 LACERATION 2 0.0002
645 OSTEOARTHRITIS 9 0.0002
646 LEUKAEMIA 2 0.0002
647 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
648 BLOOD PRESSURE DECREASED 14 0.0002
649 NERVOUSNESS 11 0.0002
650 LIP SWELLING 7 0.0002
651 HYPERHIDROSIS 27 0.0002
652 PARALYSIS 3 0.0002
653 PRODUCTIVE COUGH 10 0.0002
654 ANGINA PECTORIS 6 0.0002
655 HYPERSOMNIA 6 0.0002
656 CARDIOGENIC SHOCK 3 0.0002
657 IMPAIRED QUALITY OF LIFE 3 0.0002
658 DIZZINESS 104 0.0002
659 BLOOD GLUCOSE DECREASED 10 0.0002
660 PARAESTHESIA ORAL 3 0.0002
661 HYPOKINESIA 3 0.0002
662 DIZZINESS POSTURAL 2 0.0002
663 NEURALGIA 5 0.0002
664 PRURITUS 79 0.0002
665 DYSPHONIA 12 0.0002
666 ORAL HERPES 4 0.0002
667 TREMOR 34 0.0002
668 SURGERY 12 0.0002
669 INFLAMMATORY BOWEL DISEASE 2 0.0002
670 LUNG DISORDER 10 0.0002
671 NAUSEA 161 0.0002
672 KNEE OPERATION 2 0.0002
673 CARDIOMYOPATHY 3 0.0002
674 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
675 SKIN HAEMORRHAGE 3 0.0002
676 DISORIENTATION 8 0.0002
677 HAEMATOCRIT DECREASED 4 0.0002
678 DRUG INTERACTION 32 0.0002
679 SKIN EXFOLIATION 17 0.0002
680 INABILITY TO AFFORD MEDICATION 2 0.0002
681 WEIGHT INCREASED 45 0.0002
682 MALAISE 88 0.0002
683 THROAT IRRITATION 9 0.0002
684 AGEUSIA 5 0.0002
685 COUGH 56 0.0002
686 BLOOD POTASSIUM DECREASED 6 0.0002
687 BRAIN INJURY 2 0.0002
688 PYREXIA 69 0.0002
689 HEART RATE DECREASED 7 0.0002
690 ANAPHYLACTIC REACTION 11 0.0002
691 ABDOMINAL PAIN LOWER 5 0.0002
692 OEDEMA PERIPHERAL 24 0.0002
693 DYSKINESIA 8 0.0002
694 VOMITING 92 0.0002
695 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
696 NASOPHARYNGITIS 36 0.0002
697 INITIAL INSOMNIA 2 0.0002
698 MOBILITY DECREASED 14 0.0002
699 THYROID DISORDER 3 0.0002
700 ERYTHEMA 40 0.0002
701 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
702 INFLAMMATION 10 0.0002
703 EJECTION FRACTION DECREASED 3 0.0002
704 EYE DISCHARGE 2 0.0002
705 THERAPY PARTIAL RESPONDER 3 0.0002
706 DEAFNESS 5 0.0002
707 ARTHRITIS 15 0.0002
708 JOINT SWELLING 23 0.0002
709 GENERAL PHYSICAL HEALTH DETERIORATION 22 0.0002
710 ADVERSE DRUG REACTION 17 0.0002
711 NEUROPATHY PERIPHERAL 18 0.0002
712 ANAEMIA 36 0.0002
713 DYSGEUSIA 14 0.0002
714 RENAL FAILURE 25 0.0002
715 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
716 MOOD SWINGS 6 0.0002
717 EYE SWELLING 7 0.0002
718 CHILLS 22 0.0002
719 PRODUCT USE ISSUE 35 0.0002
720 DYSARTHRIA 7 0.0002
721 FEAR 5 0.0002
722 MUSCLE TIGHTNESS 3 0.0002
723 BACK INJURY 2 0.0002
724 GASTROINTESTINAL PAIN 2 0.0002
725 PHOTOSENSITIVITY REACTION 3 0.0002
726 STOMATITIS 11 0.0002
727 HAEMATOCHEZIA 10 0.0002
728 FEBRILE NEUTROPENIA 12 0.0002
729 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
730 COAGULOPATHY 3 0.0002
731 RASH MACULO-PAPULAR 4 0.0002
732 HYPERTENSIVE CRISIS 2 0.0002
733 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
734 TYPE 2 DIABETES MELLITUS 6 0.0002
735 FISTULA 2 0.0002
736 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
737 ANGER 6 0.0002
738 SKIN DISCOLOURATION 8 0.0002
739 THROMBOSIS 14 0.0002
740 LETHARGY 10 0.0002
741 NIGHTMARE 6 0.0002
742 BLINDNESS 7 0.0002
743 NEUROTOXICITY 3 0.0002
744 BONE PAIN 10 0.0002
745 INFLUENZA 19 0.0002
746 COLD SWEAT 3 0.0002
747 BRADYCARDIA 9 0.0002
748 BACTERAEMIA 2 0.0002
749 ATAXIA 2 0.0002
750 CONDITION AGGRAVATED 51 0.0002
751 CEREBRAL HAEMORRHAGE 6 0.0002
752 ACCIDENT 2 0.0002
753 CHEST PAIN 31 0.0002
754 RASH ERYTHEMATOUS 8 0.0002
755 URTICARIA 28 0.0002
756 BLOOD PRESSURE FLUCTUATION 4 0.0002
757 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
758 INFUSION RELATED REACTION 11 0.0002
759 HAEMOGLOBIN DECREASED 17 0.0002
760 HYPOGLYCAEMIA 8 0.0002
761 SOMNOLENCE 33 0.0002
762 RECTAL HAEMORRHAGE 7 0.0002
763 DYSPNOEA 92 0.0002
764 INJECTION SITE MASS 6 0.0002
765 EMOTIONAL DISORDER 5 0.0002
766 ABASIA 4 0.0002
767 CYST 2 0.0002
768 HAIR COLOUR CHANGES 2 0.0002
769 DRY EYE 8 0.0002
770 SWOLLEN TONGUE 5 0.0002
771 INJECTION SITE DISCOLOURATION 2 0.0002
772 HYPONATRAEMIA 9 0.0002
773 ASTHMA 18 0.0002
774 MUSCULAR WEAKNESS 18 0.0002
775 ANXIETY 45 0.0002
776 HAEMATEMESIS 4 0.0002
777 CHOLESTASIS 3 0.0002
778 POST PROCEDURAL COMPLICATION 3 0.0002
779 LOWER LIMB FRACTURE 3 0.0002
780 RENAL IMPAIRMENT 13 0.0002
781 HYPOTENSION 31 0.0002
782 HIATUS HERNIA 2 0.0002
783 HAEMATOMA 4 0.0002
784 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
785 THERAPY INTERRUPTED 11 0.0002
786 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
787 AMNESIA 10 0.0002
788 SKIN BURNING SENSATION 11 0.0002
789 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
790 DEPRESSED MOOD 8 0.0002
791 HYPERSENSITIVITY 28 0.0002
792 UPPER LIMB FRACTURE 3 0.0002
793 RENAL DISORDER 7 0.0002
794 SYNCOPE 15 0.0001
795 AGITATION 11 0.0001
796 SPINAL FRACTURE 3 0.0001
797 CARDIAC FAILURE 12 0.0001
798 BLOOD GLUCOSE INCREASED 28 0.0001
799 DISTURBANCE IN ATTENTION 8 0.0001
800 LOSS OF CONSCIOUSNESS 19 0.0001
801 PSORIATIC ARTHROPATHY 6 0.0001
802 DISEASE RECURRENCE 7 0.0001
803 NEUTROPENIA 20 0.0001
804 IMPAIRED GASTRIC EMPTYING 2 0.0001
805 CHEST DISCOMFORT 15 0.0001
806 INJECTION SITE WARMTH 3 0.0001
807 PROCEDURAL PAIN 4 0.0001
808 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
809 WOUND 4 0.0001
810 BLISTER 8 0.0001
811 BLOOD TEST ABNORMAL 2 0.0001
812 HALLUCINATION, VISUAL 3 0.0001
813 SUICIDAL IDEATION 13 0.0001
814 DIALYSIS 2 0.0001
815 JOINT INJURY 3 0.0001
816 BRONCHOSPASM 2 0.0001
817 LIVER FUNCTION TEST INCREASED 3 0.0001
818 RHINORRHOEA 9 0.0001
819 HERPES ZOSTER 8 0.0001
820 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
821 BLOOD CREATININE INCREASED 9 0.0001
822 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
823 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
824 APATHY 2 0.0001
825 CARDIAC FAILURE CONGESTIVE 11 0.0001
826 NEOPLASM MALIGNANT 9 0.0001
827 IMMUNODEFICIENCY 2 0.0001
828 SNEEZING 3 0.0001
829 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
830 DRUG DOSE OMISSION 22 0.0001
831 DERMATITIS ATOPIC 7 0.0001
832 PANCREATITIS 7 0.0001
833 HEPATIC ENZYME INCREASED 9 0.0001
834 SKIN IRRITATION 6 0.0001
835 RASH 57 0.0001
836 SHOCK 3 0.0001
837 INJECTION SITE RASH 4 0.0001
838 PERICARDIAL EFFUSION 3 0.0001
839 MYALGIA 22 0.0001
840 NERVOUS SYSTEM DISORDER 4 0.0001
841 DEVICE MALFUNCTION 9 0.0001
842 TREATMENT NONCOMPLIANCE 7 0.0001
843 BONE DENSITY DECREASED 4 0.0001
844 DRY SKIN 17 0.0001
845 MUSCULOSKELETAL STIFFNESS 11 0.0001
846 INTENTIONAL OVERDOSE 8 0.0001
847 OXYGEN SATURATION DECREASED 7 0.0001
848 HAEMORRHAGE 13 0.0001
849 MENTAL IMPAIRMENT 3 0.0001
850 EXTRA DOSE ADMINISTERED 5 0.0001
851 CHOLELITHIASIS 4 0.0001
852 OSTEONECROSIS OF JAW 3 0.0001
853 CYTOMEGALOVIRUS INFECTION 2 0.0001
854 LEUKOPENIA 6 0.0001
855 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
856 ROAD TRAFFIC ACCIDENT 5 0.0001
857 EYE PRURITUS 4 0.0001
858 PRODUCT COMPLAINT 3 0.0001
859 HEMIPARESIS 2 0.0001
860 OFF LABEL USE 103 0.0001
861 HEPATITIS 3 0.0001
862 ERECTILE DYSFUNCTION 3 0.0001
863 GASTRIC DISORDER 4 0.0001
864 UNRESPONSIVE TO STIMULI 3 0.0001
865 DYSPHAGIA 11 0.0001
866 RASH GENERALISED 3 0.0001
867 DIPLOPIA 3 0.0001
868 MENTAL DISORDER 5 0.0001
869 ECZEMA 6 0.0001
870 MUCOSAL INFLAMMATION 3 0.0001
871 MUSCULOSKELETAL PAIN 6 0.0001
872 LIVER DISORDER 5 0.0001
873 TACHYCARDIA 10 0.0001
874 ISCHAEMIC STROKE 2 0.0001
875 GALLBLADDER DISORDER 2 0.0001
876 FREQUENT BOWEL MOVEMENTS 3 0.0001
877 THROAT TIGHTNESS 3 0.0001
878 HOSPITALISATION 17 0.0001
879 BONE DISORDER 2 0.0001
880 RESPIRATORY FAILURE 8 0.0001
881 UNDERDOSE 8 0.0001
882 RESPIRATORY DISTRESS 3 0.0001
883 ABNORMAL DREAMS 3 0.0001
884 CONJUNCTIVITIS 2 0.0001
885 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
886 DEMENTIA 3 0.0001
887 THROMBOCYTOPENIA 12 0.0001
888 BACTERIAL INFECTION 2 0.0001
889 COGNITIVE DISORDER 5 0.0001
890 CEREBROVASCULAR ACCIDENT 18 0.0001
891 PAIN IN JAW 3 0.0001
892 ARRHYTHMIA 5 0.0001
893 FEELING JITTERY 2 0.0001
894 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
895 PANCREATIC CARCINOMA 3 0.0001
896 GLAUCOMA 2 0.0001
897 DYSTONIA 2 0.0001
898 NEEDLE ISSUE 3 0.0001
899 PLASMA CELL MYELOMA 4 0.0001
900 CHOKING 2 0.0001
901 INJECTION SITE REACTION 7 0.0001
902 PSYCHOTIC DISORDER 3 0.0001
903 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
904 RENAL INJURY 3 0.0001
905 RESPIRATORY DISORDER 3 0.0001
906 HEPATIC FAILURE 3 0.0001
907 APHASIA 3 0.0001
908 THERAPEUTIC RESPONSE DECREASED 6 0.0001
909 ILL-DEFINED DISORDER 6 0.0001
910 DEVICE BREAKAGE 4 0.0001
911 EPILEPSY 3 0.0001
912 LUNG NEOPLASM MALIGNANT 4 0.0001
913 CARDIAC ARREST 8 0.0001
914 FEMUR FRACTURE 3 0.0001
915 TREATMENT FAILURE 8 0.0001
916 KNEE ARTHROPLASTY 2 0.0001
917 IRRITABLE BOWEL SYNDROME 2 0.0001
918 DISEASE PROGRESSION 11 0.0001
919 DEVICE LEAKAGE 4 0.0001
920 DIABETES MELLITUS 7 0.0001
921 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
922 INJECTION SITE BRUISING 7 0.0001
923 INJECTION SITE HAEMORRHAGE 7 0.0001
924 NEOPLASM PROGRESSION 3 0.0001
925 RASH MACULAR 3 0.0001
926 INJURY 6 0.0001
927 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
928 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
929 HEPATIC CANCER 2 0.0001
930 DRUG INEFFECTIVE 109 0.0001
931 ACCIDENTAL OVERDOSE 3 0.0001
932 INJECTION SITE URTICARIA 2 0.0001
933 DEATH 70 0.0001
934 AGGRESSION 4 0.0001
935 DYSPNOEA EXERTIONAL 3 0.0001
936 UNEVALUABLE EVENT 6 0.0001
937 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
938 GASTRIC CANCER 2 0.0001
939 DEVICE ISSUE 7 0.0001
940 ANAPHYLACTIC SHOCK 2 0.0001
941 EXPOSURE VIA SKIN CONTACT 2 0.0001
942 DEEP VEIN THROMBOSIS 5 0.0001
943 PSORIASIS 10 0.0001
944 APPLICATION SITE ERYTHEMA 2 0.0001
945 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
946 ABNORMAL BEHAVIOUR 3 0.0001
947 BREAST CANCER FEMALE 2 0.0001
948 ABORTION SPONTANEOUS 3 0.0001
949 MYOCARDIAL INFARCTION 13 0.0001
950 BLOOD BILIRUBIN INCREASED 2 0.0001
951 PULMONARY EMBOLISM 7 0.0001
952 PRODUCT QUALITY ISSUE 10 0.0001
953 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
954 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
955 INJECTION SITE ERYTHEMA 9 0.0001
956 DRUG ABUSE 6 0.0001
957 PANCYTOPENIA 4 0.0001
958 RHEUMATOID ARTHRITIS 8 0.0001
959 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
960 ACUTE MYOCARDIAL INFARCTION 2 0.0001
961 ANGIOEDEMA 3 0.0001
962 WHEEZING 4 0.0001
963 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
964 COMA 3 0.0001
965 PROSTATE CANCER 5 0.0001
966 INTERSTITIAL LUNG DISEASE 3 0.0001
967 INJECTION SITE PRURITUS 4 0.0001
968 INJECTION SITE PAIN 18 0.0001
969 PRODUCT STORAGE ERROR 5 0.0001
970 INCORRECT DOSE ADMINISTERED 13 0.0001
971 OVERDOSE 12 0.0001
972 ADVERSE EVENT 5 0.0001
973 HEPATIC FUNCTION ABNORMAL 2 0.0001
974 BLADDER CANCER 3 0.0001
975 SUICIDE ATTEMPT 3 0.0000
976 DEVICE DISLOCATION 2 0.0000
977 DEVICE DIFFICULT TO USE 3 0.0000
978 BREAST CANCER 4 0.0000
979 COLORECTAL CANCER 2 0.0000
980 ACNE 3 0.0000
981 INJECTION SITE SWELLING 3 0.0000
982 NO ADVERSE EVENT 7 0.0000
983 DRUG DEPENDENCE 6 0.0000
984 DRUG EFFECT DECREASED 2 0.0000
985 COMPLETED SUICIDE 3 0.0000
986 DRUG WITHDRAWAL SYNDROME 3 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
988 TOXICITY TO VARIOUS AGENTS 4 0.0000